Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Multiple Sclerosis

  Free Subscription


1 AJNR Am J Neuroradiol
2 Ann Neurol
2 Arch Phys Med Rehabil
2 BMC Neurol
2 J Neurol
1 Mult Scler
1 Neurol Genet
1 Neurology
3 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJNR Am J Neuroradiol

  1. LAKHANI DA, Schilling KG, Xu J, Bagnato F, et al
    Advanced Multicompartment Diffusion MRI Models and Their Application in Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2020 Apr 30. pii: ajnr.A6484. doi: 10.3174/ajnr.A6484.
    PubMed         Abstract available

    Ann Neurol

  2. MATIAS-GUIU JA, Cabrera-Martin MN, Pytel V, Montero P, et al
    Amyloid PET in Multiple Sclerosis: between amyloid deposition and myelin damage.
    Ann Neurol. 2020 May 1. doi: 10.1002/ana.25759.

  3. ZEYDAN B, Kantarci K, Kantarci OH
    Reply to "Amyloid PET in Multiple Sclerosis: between amyloid deposition and myelin damage".
    Ann Neurol. 2020 Apr 30. doi: 10.1002/ana.25758.

    Arch Phys Med Rehabil

  4. LO J, Chan L, Flynn S
    A Systematic Review of the Incidence, Prevalence, Costs, and Activity/Work Limitations of Amputation, Osteoarthritis, Rheumatoid Arthritis, Back Pain, Multiple Sclerosis, Spinal Cord Injury, Stroke, and Traumatic Brain Injury in the United States: A 2
    Arch Phys Med Rehabil. 2020 Apr 24. pii: S0003-9993(20)30216.
    PubMed         Abstract available

  5. KIM Y, Mehta T, Lai B, Motl RW, et al
    Immediate and Sustained Effects of Interventions for Changing Physical Activity in People with Multiple Sclerosis: Meta-Analysis of Randomized Controlled Trials.
    Arch Phys Med Rehabil. 2020 Apr 25. pii: S0003-9993(20)30217.
    PubMed         Abstract available

    BMC Neurol

  6. ROMANELLI RJ, Huang Q, Lacy J, Hashemi L, et al
    Multiple sclerosis in a multi-ethnic population from Northern California: a retrospective analysis, 2010-2016.
    BMC Neurol. 2020;20:163.
    PubMed         Abstract available

  7. WIENEMANN T, Muller AK, MacKenzie C, Bielor C, et al
    Cryptococcal meningoencephalitis in an IgG2-deficient patient with multiple sclerosis on fingolimod therapy for more than five years - case report.
    BMC Neurol. 2020;20:158.
    PubMed         Abstract available

    J Neurol

  8. CHEN MH, Wylie GR, Sandroff BM, Dacosta-Aguayo R, et al
    Neural mechanisms underlying state mental fatigue in multiple sclerosis: a pilot study.
    J Neurol. 2020 Apr 29. pii: 10.1007/s00415-020-09853.
    PubMed         Abstract available

  9. SABIN J, Urtiaga S, Pilo B, Thuissard I, et al
    Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population.
    J Neurol. 2020 Apr 29. pii: 10.1007/s00415-020-09848.
    PubMed         Abstract available

    Mult Scler

  10. FOX E, Lovett-Racke AE, Gormley M, Liu Y, et al
    A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis.
    Mult Scler. 2020 Apr 30:1352458520918375. doi: 10.1177/1352458520918375.
    PubMed         Abstract available

    Neurol Genet

  11. DEGASPERIS SM, Bernard G, Wolf NI, Miller E, et al
    4H leukodystrophy: Mild clinical phenotype and comorbidity with multiple sclerosis.
    Neurol Genet. 2020;6:e409.


  12. ARUN T, Pattison L, Palace J
    Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective cohort study.
    Neurology. 2020 Apr 30. pii: WNL.0000000000009491.
    PubMed         Abstract available

    PLoS One

  13. OHLMEIER C, Gothe H, Haas J, Osowski U, et al
    Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data.
    PLoS One. 2020;15:e0231846.
    PubMed         Abstract available

  14. GOUGH N, Brkan L, Subramaniam P, Chiuccariello L, et al
    Feasibility of remotely supervised transcranial direct current stimulation and cognitive remediation: A systematic review.
    PLoS One. 2020;15:e0223029.
    PubMed         Abstract available

  15. GOLDMAN MD, Dwyer L, Coleman R, Sohn MW, et al
    Patient-specific factors modulate leukocyte response in dimethyl fumarate treated MS patients.
    PLoS One. 2020;15:e0228617.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.